Clinical Trial: A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity

U.S., Dec. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07291232) titled 'A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity' on Nov. 19.

Brief Summary: This study is to assess adverse events, change in body weight and pharmacokinetics in adult participants with obesity receiving ABBV-295 subcutaneous injections or matching placebo.

Study Start Date: Nov. 19

Study Type: INTERVENTIONAL

Condition: Obesity

Intervention: DRUG: ABBV-295

Subcutaneous Injections

DRUG: Placebo

Subcutaneous Injections

Recruitment Status: RECRUITING

Sponsor: AbbVie

Disclaimer: Curated by HT Syndication....